Monitoring Agency Report for the quarter ended 31st March, 2025
NOVAAGRI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Nova Agritech's IPO (Jan 2024) raised net proceeds of Rs. 100.95 crore, of which Rs. 76 crore (about 75%) has been utilized as of 31st March 2025, with Rs. 24.95 crore still unutilized and parked in fixed deposits earning 5.50%-7.62% interest. The funds were allocated across five objects: Rs. 14.20 crore for a new formulation plant at subsidiary NASPL (Rs. 13.76 crore spent), Rs. 10.49 crore for expansion of the existing plant (Rs. 7.89 crore spent), Rs. 26.65 crore for company working capital (Rs. 17.03 crore spent), Rs. 43.36 crore for subsidiary NASPL working capital (Rs. 31.09 crore spent), and Rs. 6.23 crore for general corporate purposes (fully utilized). CARE Ratings, the monitoring agency, reported no deviation from the stated objects or material changes in means of finance. Some delays were flagged in capex spending for FY24, though the offer document permitted carry-forward of unspent amounts. A few insecticide product registrations for the company and its subsidiary remain pending.
This is a routine regulatory disclosure and broadly neutral for shareholders — the company has used IPO funds for stated purposes without any major diversions, and idle funds are earning reasonable FD returns. However, investors may note the slow pace of capex deployment (only Rs. 21.65 crore of Rs. 24.69 crore spent on plant-related projects after over a year) and pending regulatory approvals which could affect future business plans.